APA (7th ed.) Citation

Arqueros, C., Gallardo, A., Vidal, S., Osuna-Gómez, R., Tibau, A., Lidia Bell, O., . . . Barnadas, A. (2024). Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy. International Journal of Molecular Sciences, 25(5), 2627. https://doi.org/10.3390/ijms25052627

Chicago Style (17th ed.) Citation

Arqueros, Cristina, et al. "Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy." International Journal of Molecular Sciences 25, no. 5 (2024): 2627. https://doi.org/10.3390/ijms25052627.

MLA (9th ed.) Citation

Arqueros, Cristina, et al. "Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy." International Journal of Molecular Sciences, vol. 25, no. 5, 2024, p. 2627, https://doi.org/10.3390/ijms25052627.